Skip to content

Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010;59(5):605-11. PMID 20427395

One-paragraph summary

In May 2000 the municipal water supply of Walkerton, Ontario was contaminated with Escherichia coli O157:H7 and Campylobacter jejuni, causing a large community outbreak of acute gastroenteritis. The Walkerton Health Study enrolled residents in 2002–2003 and reassessed them annually. Of 4,561 participants, 2,451 returned for the eight-year assessment and 1,166 were eligible for the post-infectious IBS cohort (688 women; mean age 46.2 years), having had no prior IBS or inflammatory bowel disease. Among the 742 eligible participants who had suffered acute gastroenteritis during the outbreak, IBS prevalence by Rome I criteria fell from 28.3% at 2–3 years to 15.4% at 8 years but remained significantly elevated versus unexposed controls (OR 3.12, 95% CI 1.99–5.04). Independent risk factors for persisting IBS at eight years were female sex, younger age, prior anxiety or depression, and fever or weight loss during the acute illness. IBS subtypes were not stable over time. The companion papers report the two-year incidence (Marshall 2006, PMID 16890598), the paediatric cohort (Thabane 2010, PMID 20179687), a validated risk score (Thabane 2009, PMID 19568228) and excess dyspepsia in the same cohort at eight years (Ford 2010, PMID 20117111).

Key findings

  • Acute bacterial gastroenteritis can trigger IBS symptoms that persist for at least eight years.
  • Prevalence declines — 28.3% → 15.4% — but does not return to background: OR 3.12 (1.99–5.04) versus unexposed at eight years.
  • Host factors (female sex, younger age, pre-existing anxiety or depression) and acute-illness severity (fever, weight loss) both predict persistence.
  • Subtype was unstable across the follow-up, which limits subtype-directed management in post-infectious disease.
  • At two years the gradient by exposure certainty was clear: Rome I IBS in 10.1% of 701 unexposed controls, 27.5% of 904 with self-reported gastroenteritis and 36.2% of 464 with clinically suspected gastroenteritis (Marshall 2006, PMID 16890598).
  • The same exposure produced excess dyspepsia at eight years (multivariate OR 2.09, 1.58–2.78 broad definition; 2.30, 1.63–3.26 by Rome II) (Ford 2010, PMID 20117111).

Limitations

  • Rome I criteria, now three revisions out of date; prevalence figures are not comparable to Rome IV or Rome V estimates.
  • Attrition: 2,451 of 4,561 returned at eight years, and exposure status for a large group rested on self-report.
  • Single outbreak, single pathogen pair, single North American town — pathogen-specific generalisation is unsupported, and meta-analyses disagree about whether pathogen identity matters (Svendsen 2019, PMID 31112663; Porcari 2024, PMID 39013599).
  • Observational: no intervention was tested. Targeted PubMed and ClinicalTrials.gov searches on 2026-09-02 retrieved no prevention trial enriched with the identified risk factors.

Why it matters

Walkerton is the closest thing IBS has to a natural experiment with a datable exposure, an unexposed control group and long follow-up. It establishes three facts that few other designs establish as cleanly: a single resolved bacterial insult can produce years of symptoms; the risk decays slowly but incompletely; and the same insult produces both bowel and gastroduodenal disease, which supports a shared gut–brain diathesis rather than organ-specific injury. It also produced a nine-variable pre-symptomatic risk-prediction tool with area under the ROC 0.70 separating strata with 10%, 35% and 60% post-infectious IBS rates (Thabane 2009, PMID 19568228). Targeted PubMed and registry searches on 2026-09-02 retrieved no prevention trial enriched with that score.

Cited by wiki pages

  • post-infectious-ibs
  • overlap-with-functional-dyspepsia